Skip to content
★ Sign in to follow
RW

Robert W. Hooper

Executive
Total declarations
21
Company
1
▲ Purchases (19 ops.)
€266k
▼ Sales (0 ops.)
—

Latest filing published 03 Oct 2018 for Imunon, Inc., €12k.

Filing timeline

BuySale
Robert W. Hooper

Insider track record

Disclosed buys
19
Disclosed sells
0
Signal history

Closed purchases

Market purchases
19
Positive at T+90
60%
Median T+90
+6.5%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 03 Oct 2018 · 2959 days ago · €12k
    -37.3%
    Entry US$545.87 · Close at T+365 US$342.39
  • Filed 02 Mar 2018 · 3174 days ago · €24k
    -11.8%
    Entry US$479.35 · Close at T+365 US$422.61
  • Filed 30 Aug 2012 · 5184 days ago · €9,277
    -78.9%
    Entry US$67,121.03 · Close at T+365 US$14,189.19
  • Filed 22 Mar 2012 · 5345 days ago · €6,629
    -57.8%
    Entry US$24,553.47 · Close at T+365 US$10,364.28

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Robert W. Hooper: trading record in brief

Robert W. Hooper discloses dealings in Imunon, Inc. to SEC (Form 4). Between 10 August 2010 and 3 October 2018, the trades on record add up to 21 filings.

On the market, this insider has only ever bought: 19 purchases, €266k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant. 2018 to date brings 3 purchases and no sales.

A typical purchase (the median) is worth €10k. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 5 purchases show a median change of +6.5%, with the price up in 60% of them. These figures describe past trades and do not predict future prices.

The newest entry dates from 3 October 2018: an open-market purchase of €12k, in Imunon, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Robert W. Hooper

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total
  • ▲
    DirectorExecutivesImunon, Inc.
    13,770 USD28SEC
    5,100 shares@ US$2.7025.1% of flowCelsion Corporation Common StockSEC:0001437749-18-017869:0
    Canonical exit: 31 Dec 2018 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    13,230 USD29SEC
    4,900 shares@ US$2.7024.3% of flowCelsion Corporation Common StockSEC:0001437749-18-017869:1
    Canonical exit: 1 Jan 2019 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    29,703 USD31SEC
    13,625 shares@ US$2.1850.5% of flowCelsion Corporation Common StockSEC:0001437749-18-003797:0
    Canonical exit: 21 May 2018 (T+90)
  • ◆
    DirectorExecutivesImunon, Inc.
    0SEC
    5,000 sharesCelsion Corporation Common StockSEC:0001437749-16-024782:0
  • ▲
    DirectorExecutivesImunon, Inc.
    10,000 USD0SEC
    4,000 shares@ US$2.50Celsion Corporation Common StockSEC:0001437749-14-020737:0
    Canonical exit: 11 Feb 2015 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    60,320 USD0SEC
    11,600 shares@ US$5.20Celsion Corporation Common StockSEC:0000749647-12-000042:0
    Canonical exit: 13 Feb 2013 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    5,215 USD0SEC
    1,060 shares@ US$4.92Celsion Corporation Common StockSEC:0001437749-12-009309:0
    Canonical exit: 9 Dec 2012 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    494 USD0SEC
    100 shares@ US$4.94Celsion Corporation Common StockSEC:0001437749-12-009309:1
    Canonical exit: 9 Dec 2012 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    18,848 USD0SEC
    3,800 shares@ US$4.96Celsion Corporation Common StockSEC:0001437749-12-009309:2
    Canonical exit: 9 Dec 2012 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    7,699 USD0SEC
    1,549 shares@ US$4.97Celsion Corporation Common StockSEC:0001437749-12-009309:3
    Canonical exit: 9 Dec 2012 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    17,280 USD0SEC
    3,491 shares@ US$4.95Celsion Corporation Common StockSEC:0001437749-12-009309:4
    Canonical exit: 9 Dec 2012 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    11,625 USD0SEC
    2,500 shares@ US$4.65Celsion Corporation Common StockSEC:0000749647-12-000035:0
    Canonical exit: 27 Nov 2012 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    8,000 USD0SEC
    4,520 shares@ US$1.77Celsion Corporation Common StockSEC:0000749647-12-000029:0
    Canonical exit: 17 Aug 2012 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    8,775 USD0SEC
    4,500 shares@ US$1.95Celsion Corporation Common StockSEC:0000749647-12-000027:0
    Canonical exit: 19 Jun 2012 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    1,029 USD0SEC
    490 shares@ US$2.10Celsion Corporation Common StockSEC:0000749647-11-000157:0
    Canonical exit: 4 Mar 2012 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    19,971 USD0SEC
    9,510 shares@ US$2.10Celsion Corporation Common StockSEC:0000749647-11-000157:1
    Canonical exit: 5 Mar 2012 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    15,000 USD0SEC
    5,000 shares@ US$3.00Celsion Corporation Common StockSEC:0000749647-11-000115:0
    Canonical exit: 14 Nov 2011 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    24,800 USD0SEC
    8,000 shares@ US$3.10Celsion Corporation Common StockSEC:0000749647-11-000074:0
    Canonical exit: 11 Sept 2011 (T+90)
  • ▲
    DirectorExecutivesImunon, Inc.
    71,762 USD0SEC
    25,907 shares@ US$2.77Celsion Corporation Common StockSEC:0000749647-11-000069:0
    Canonical exit: 24 Aug 2011 (T+90)
  • ●
    DirectorExecutivesImunon, Inc.
    12,000 USD0SEC
    5,000 shares@ US$2.40Celsion Corporation Common StockSEC:0000749647-11-000037:0
  • ▲
    DirectorExecutivesImunon, Inc.
    10,050 USD0SEC
    3,000 shares@ US$3.35Celsion Corporation Common StockSEC:0000749647-10-000046:0
    Canonical exit: 8 Nov 2010 (T+90)

21 of 21 declarations